Where hyperglycemia is shown to destabilize HIF1 levels, there are also reports of targeting HIF1 leading to amelioration of obesity and insulin resistance, further elaborating on its potential as therapeutic agent [160]. The gene discussed is HIF1A; the disease is obesity due to melanocortin 4 receptor deficiency.